- Home
- Industry Reports
- Biotechnology
- Healthcare
- Middle East and Africa Biobanks Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)
The biobank is a type of biorepository which stores the biological samples, usual humans for use in future research.These biobanks play a vital role in drug discovery and disease research. Biobanks give access to samples which are collected by doctors for their research studies. These storages may range from a refrigerator to warehouse, hospitals, universities and pharmaceutical companies.
The Middle East & Africa Biobanks Market Segments Size & Growth:
The Middle East & Africa BiobanksMarket is accounted for $38billion in 2017 and expected to grow at a CAGR of 11% to reach $62 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth due to rapid growth in population increase in chronic diseases, and advancements in biobanking techniques. However, surveillance issues and storage problems hinder the growth of theMiddle East & Africa biobanks market.
The Middle East & Africa Biobanks Market Segments Share:
The Middle East & Africa BiobanksMarket is categorised into by-product which consists of consumables, services, equipment, and software. Consumables have the most significant share due to the increase in some biobanks. By samples, Biobanksmarket is segmented as biological fluids, human tissues, blood products, and human waste products. Among all human tissues are expected to have high growth rate during the forecast period 2018-2024, because of increase in research. Drug discovery and research are leading in biobanks market among application due to the rise in technological advancements, research, and manufacturing of drugs.
By Geography, South Africa is dominating the biobanks market, and the growth in the Middle East & Africa is mainly attributed because of the increasing demand for personalised medicine and rise in cancer cases. Furthermore, Middle East is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.
The Middle East & Africa Biobanks Market Segments Trends:
- In a recent study, biological samples and genomic data an accelerate diagnosis and therapeutic research for an NGY1 deficiency.
- Qiagen, bioinformatics has acquired Omic Soft Corporation providing access to the multi-omics database in January 2017.
The Middle East & Africa Biobanks Research Report:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and the global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- DNA Genotek Inc.
- Qiagen N.V.
- Bio Storage Technologies
- Covance Inc.
- Hamilton Company
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in precision medicine
4.1.2 Research and development for clinical trials
4.1.3 Advancement in Biobanks Marketing techniques
4.2 Restraints
4.2.1 Surveillance issues
4.2.2 Problems in storage
4.2.3 Expensive procedures
4.3 Opportunities
4.3.1 Research and understanding on various diseases
4.4 Challenges
4.4.1.Informatics
Chapter 5 Middle East & Africa Biobanks Markets– By Product
5.1 Consumables
5.2 Services
5.3 Equipment
5.4 Software
Chapter 6 Middle East & Africa Biobanks Markets- By Sample
6.1Biological Fluids
6.2 Human Tissues
6.3 Blood Products
6.4 Human Waste Products
Chapter 7 Middle East & AfricaBiobanks Markets- By Application
7.1 Life Science Research
7.2 Drug Discovery
7.3 Disease Research
Chapter 8 Middle East & Africa Biobanks Markets- By Geography
8.1 Introduction
8.2 The Middle East & Africa
8.2.1.Middle East
8.2.2.Africa
Chapter 9 Middle East & Africa Biobanks Markets- Company Profiles
9.1.BioCision
9.2.CryoXtract
9.3Taylor-Wharton
9.4.Cryo BioSystems
9.5.Beckman Coulter
9.6. Bio Storage Technologies
9.7.DNA Genotek Inc.
9.8.Core Dynamics Ltd.
9.9.Covance Inc.
9.10.Thermo Fisher Scientific Inc.
9.11.Tissue Solutions
9.12.Hamilton Company
9.13.Stemcell Technologies Inc.
9.14.Qiagen N.V.
9.15.Tecan
Chapter 10 Middle East & Africa Biobanks Markets- Competitive Landscape
10.1.Market Share Analysis
10.2.Strategies Adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2.Analysts Opinions
11.3.Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,991.88 - €6,639.62
- INR: ₹180,043.09 - ₹600,143.64
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,706.75 - £5,689.16
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
The biobank is a type of biorepository which stores the biological samples, usual humans for use in future research.These biobanks play a vital role in drug discovery and disease research. Biobanks give access to samples which are collected by doctors for their research studies. These storages may range from a refrigerator to warehouse, hospitals, universities and pharmaceutical companies.
The Middle East & Africa Biobanks Market Segments Size & Growth:
The Middle East & Africa BiobanksMarket is accounted for $38billion in 2017 and expected to grow at a CAGR of 11% to reach $62 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth due to rapid growth in population increase in chronic diseases, and advancements in biobanking techniques. However, surveillance issues and storage problems hinder the growth of theMiddle East & Africa biobanks market.
The Middle East & Africa Biobanks Market Segments Share:
The Middle East & Africa BiobanksMarket is categorised into by-product which consists of consumables, services, equipment, and software. Consumables have the most significant share due to the increase in some biobanks. By samples, Biobanksmarket is segmented as biological fluids, human tissues, blood products, and human waste products. Among all human tissues are expected to have high growth rate during the forecast period 2018-2024, because of increase in research. Drug discovery and research are leading in biobanks market among application due to the rise in technological advancements, research, and manufacturing of drugs.
By Geography, South Africa is dominating the biobanks market, and the growth in the Middle East & Africa is mainly attributed because of the increasing demand for personalised medicine and rise in cancer cases. Furthermore, Middle East is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.
The Middle East & Africa Biobanks Market Segments Trends:
- In a recent study, biological samples and genomic data an accelerate diagnosis and therapeutic research for an NGY1 deficiency.
- Qiagen, bioinformatics has acquired Omic Soft Corporation providing access to the multi-omics database in January 2017.
The Middle East & Africa Biobanks Research Report:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and the global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- DNA Genotek Inc.
- Qiagen N.V.
- Bio Storage Technologies
- Covance Inc.
- Hamilton Company
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in precision medicine
4.1.2 Research and development for clinical trials
4.1.3 Advancement in Biobanks Marketing techniques
4.2 Restraints
4.2.1 Surveillance issues
4.2.2 Problems in storage
4.2.3 Expensive procedures
4.3 Opportunities
4.3.1 Research and understanding on various diseases
4.4 Challenges
4.4.1.Informatics
Chapter 5 Middle East & Africa Biobanks Markets– By Product
5.1 Consumables
5.2 Services
5.3 Equipment
5.4 Software
Chapter 6 Middle East & Africa Biobanks Markets- By Sample
6.1Biological Fluids
6.2 Human Tissues
6.3 Blood Products
6.4 Human Waste Products
Chapter 7 Middle East & AfricaBiobanks Markets- By Application
7.1 Life Science Research
7.2 Drug Discovery
7.3 Disease Research
Chapter 8 Middle East & Africa Biobanks Markets- By Geography
8.1 Introduction
8.2 The Middle East & Africa
8.2.1.Middle East
8.2.2.Africa
Chapter 9 Middle East & Africa Biobanks Markets- Company Profiles
9.1.BioCision
9.2.CryoXtract
9.3Taylor-Wharton
9.4.Cryo BioSystems
9.5.Beckman Coulter
9.6. Bio Storage Technologies
9.7.DNA Genotek Inc.
9.8.Core Dynamics Ltd.
9.9.Covance Inc.
9.10.Thermo Fisher Scientific Inc.
9.11.Tissue Solutions
9.12.Hamilton Company
9.13.Stemcell Technologies Inc.
9.14.Qiagen N.V.
9.15.Tecan
Chapter 10 Middle East & Africa Biobanks Markets- Competitive Landscape
10.1.Market Share Analysis
10.2.Strategies Adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2.Analysts Opinions
11.3.Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.